3-(acetamidomethyl)furan | 187590-37-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: 3-(acetamidomethyl)furan
• 英文别名: N-(furan-3-ylmethyl)acetamide
• CAS: 187590-37-0
• 化学式: C₇H₉NO₂
• 分子量: 139.154
• InChiKey: QTAIOFTXBJBYDK-UHFFFAOYSA-N

物化性质

• 沸点：
  309.1±25.0 °C(Predicted)
• 密度：
  1.091±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(acetamidomethyl)furan 在 三氯化铝 作用下， 以 乙醇 为溶剂， 反应 1.0h， 生成 N-[[5-[2-[[N'-[2-(2-methoxyphenyl)ethyl]carbamimidoyl]amino]-1,3-thiazol-4-yl]furan-3-yl]methyl]acetamide
  参考文献：
  名称：

  Anti-Helicobacter pylori Agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles

  摘要：

  A series of 2-[(arylalkyl)guanidinol-4-[(5-acetamidomethyl)furan-2-yl]thiazoles and some 4-acetamidomethyl positional isomers were synthesized and evaluated for antimicrobial activity against Helicobacter pylori. Among the compounds that had potent antimicrobial activity (MIC < 0.1 mu g/mL), compounds 31 and 36 additionally possessed H2 antagonist and gastric antisecretory activities. Though compound 51, an analogue incorporating a methyl group onto the furan nucleus of 36, and compound 54, a positional isomer of 51, also showed potent anti-H. pylori activity, the H2 antagonism profile was eliminated from these compounds. Thus, two types of potent anti-H. pylori agents could be derived from the same scaffold.

  DOI：

  10.1021/jm9900671
• 作为产物：
  描述：

  3-(phthalimidomethyl)furan 在 一水合肼 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 反应 7.0h， 生成 3-(acetamidomethyl)furan
  参考文献：
  名称：

  Anti-Helicobacter pylori Agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles

  摘要：

  A series of 2-[(arylalkyl)guanidinol-4-[(5-acetamidomethyl)furan-2-yl]thiazoles and some 4-acetamidomethyl positional isomers were synthesized and evaluated for antimicrobial activity against Helicobacter pylori. Among the compounds that had potent antimicrobial activity (MIC < 0.1 mu g/mL), compounds 31 and 36 additionally possessed H2 antagonist and gastric antisecretory activities. Though compound 51, an analogue incorporating a methyl group onto the furan nucleus of 36, and compound 54, a positional isomer of 51, also showed potent anti-H. pylori activity, the H2 antagonism profile was eliminated from these compounds. Thus, two types of potent anti-H. pylori agents could be derived from the same scaffold.

  DOI：

  10.1021/jm9900671

文献信息

• 5-PHENYLTHIAZOLE DERIVATIVES AND USE AS PI3 KINASE INHIBITORS
  申请人：Bruce Ian

  公开号：US20100093690A1

  公开（公告）日：2010-04-15

  Compounds of formula I in free or salt form, wherein R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

  式I的化合物，无论是自由形式还是盐形式，其中R1、R2、R3、R4和R5的含义如规范中所示，对于治疗由磷脂酰肌醇3-激酶介导的疾病是有用的。还描述了含有这些化合物的制药组合物以及制备这些化合物的过程。
• Processes For Forming Amide Bonds And Compositions Related Thereto
  申请人：Liebeskind Lanny S.

  公开号：US20120107902A1

  公开（公告）日：2012-05-03

  The disclosure relates to methods for producing amide bonds and reagents related thereto. In some embodiments, the disclosure relates to methods of producing an amide comprising mixing an O-silylated thionoester and an amine under conditions such that an amide is formed. In another embodiment, the disclosure relates to mixing a thiolacid, a silylating agent, and an amine under conditions such that an amide is formed.

  本披露涉及生产酰胺键的方法及相关试剂。在某些实施例中，本披露涉及生产酰胺的方法，包括混合O-硅基硫代酯和胺，以形成酰胺。在另一实施例中，本披露涉及混合硫酸、硅基化试剂和胺的方法，以形成酰胺。
• PROCESSES FOR FORMING AMIDE BONDS AND COMPOSITIONS RELATED THERETO
  申请人：EMORY UNIVERSITY

  公开号：US20150315129A1

  公开（公告）日：2015-11-05

  The disclosure relates to methods for producing amide bonds and reagents related thereto. In some embodiments, the disclosure relates to methods of producing an amide comprising mixing an O-silylated thionoester and an amine under conditions such that an amide is formed. In another embodiment, the disclosure relates to mixing a thiolacid, a silylating agent, and an amine under conditions such that an amide is formed.

  本公开涉及制备酰胺键及其相关试剂的方法。在一些实施例中，本公开涉及制备酰胺的方法，包括混合O-硅基硫酰酯和胺，在形成酰胺的条件下进行。在另一实施例中，本公开涉及混合硫酸酯、硅基化试剂和胺，在形成酰胺的条件下进行。
• AMIDE SUBSTITUTED IMIDAZOQUINOLINES
  申请人：3M Innovative Properties Company

  公开号：EP1187613A1

  公开（公告）日：2002-03-20
• EP1187613A4
  申请人：——

  公开号：EP1187613A4

  公开（公告）日：2002-07-24